Kezar Life Sciences, Inc. (KZR): Price and Financial Metrics
GET POWR RATINGS... FREE!
KZR Stock Price Chart Interactive Chart >
KZR Price/Volume Stats
| Current price | $5.24 | 52-week high | $18.55 |
| Prev. close | $4.99 | 52-week low | $4.61 |
| Day low | $4.99 | Volume | 726,300 |
| Day high | $5.32 | Avg. volume | 832,099 |
| 50-day MA | $11.85 | Dividend yield | N/A |
| 200-day MA | $11.49 | Market Cap | 316.58M |
Kezar Life Sciences, Inc. (KZR) Company Bio
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Its lead product candidate, KZR-616, a selective immunoproteasome inhibitor that is in Phase 1b/2 clinical trials in lupus and lupus nephritis The company was incorporated in 2015 and is headquartered in South San Francisco, California.
Latest KZR News From Around the Web
Below are the latest news stories about Kezar Life Sciences Inc that investors may wish to consider to help them evaluate KZR as an investment opportunity.
Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ...Cambridge, MA, based Investment company Opaleye Management Inc. (Current Portfolio) buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics Pharmaceuticals Inc, Amicus Therapeutics Inc, Merus NV, sells ESSA Pharma Inc, Seres Therapeutics Inc, CM Life Sciences Inc, Lumos Pharma Inc, Kezar Life Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Opaleye Management Inc.. |
Kezar Life Sciences Inc. (NASDAQ:KZR) Shares Are Up 13.45 Percent In A Week But Can The Gains Continue?In last trading session, Kezar Life Sciences Inc. (NASDAQ:KZR) saw 0.41 million shares changing hands with its beta currently measuring 0.11. Companys recent per share price level of $15.69 trading at $0.69 or 4.60% at ring of the bell on the day assigns it a market valuation of $729.90M. That closing price of KZRs stock Kezar Life Sciences Inc. (NASDAQ:KZR) Shares Are Up 13.45 Percent In A Week But Can The Gains Continue? Read More » |
Kezar Life Sciences (NASDAQ:KZR) Reaches New 52-Week High at $15.88Kezar Life Sciences, Inc. (NASDAQ:KZR) shares reached a new 52-week high on Thursday . The company traded as high as $15.88 and last traded at $15.77, with a volume of 11332 shares changing hands. The stock had previously closed at $15.00. A number of equities research analysts recently weighed in on KZR shares. Wells Fargo [] |
-$0.29 Earnings Per Share Expected for Kezar Life Sciences, Inc. (NASDAQ:KZR) This QuarterWall Street analysts forecast that Kezar Life Sciences, Inc. (NASDAQ:KZR) will announce ($0.29) earnings per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Kezar Life Sciences earnings. The highest EPS estimate is ($0.27) and the lowest is ($0.30). Kezar Life Sciences reported earnings of ($0.22) per share during the same [] The post -$0.29 Earnings Per Share Expected for Kezar Life Sciences, Inc. (NASDAQ:KZR) This Quarter appeared first on ETF Daily News . |
Kezar Life Sciences (NASDAQ:KZR) Trading Up 7.6%Kezar Life Sciences, Inc. (NASDAQ:KZR)s share price was up 7.6% during trading on Thursday . The company traded as high as $13.89 and last traded at $13.77. Approximately 6,571 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 552,756 shares. The stock had previously closed at $12.80. A [] |
KZR Price Returns
| 1-mo | -55.89% |
| 3-mo | -64.71% |
| 6-mo | -62.19% |
| 1-year | -8.39% |
| 3-year | -46.20% |
| 5-year | N/A |
| YTD | -68.66% |
| 2021 | 220.31% |
| 2020 | 30.17% |
| 2019 | -83.01% |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...